Hormone Replacement Therapy News
Danish researches have discovered that women taking hormone replacement therapy may be more likely to suffer severe asthma attacks. A study of more than 23,000 women revealed that women who take hormone therapy for 3 years are 34% more likely to develop asthma. Women who take hormone therapy for ten years are at a 50% greater risk than women who don’t use hormone therapy. More »
The law firm of Hissey Kientz, LLP wishes to announce the launch of its new Hormone Replacement Therapy Message Board (http://hrtboard.com/). The site will serve as a forum for hormone therapy users to share comments, read about the cases of other hormone therapy patients and answer frequently asked questions about hormone therapy. More »
By William Heisel
It’s not as seductive as a candlelit bedroom.
But a dinner with medical colleagues after a board meeting can exert a powerful a pull on talented scientists flirting with the drug industry. More »
On November 2, 2009, the United States Court of Appeals for the Eighth Circuit issued its long-awaited decision in Scroggin v. Wyeth (Case No. 08-2555). The decision gives the green light for federal trials on Wyeth’s and Pfizer’s hormone therapy drugs. In affirming judgment on a jury verdict of compensatory damages, the federal appellate court rejected the defendants’ claims that plaintiffs like Donna Scroggin cannot prove that hormone therapy caused their breast cancer. It also found that the statute of limitations began to run from the announcement of the startling results of the Women’s Health Initiative study (“WHI”) in July, 2002. More »
Minnesota Supreme Court Confirms that Minnesota’s Statutes of Limitations Govern Out-of-State Claims
On September 2, 2009, the Minnesota Supreme Court held that Minnesota’s statute of limitations would govern all personal injury claims properly brought in Minnesota courts. In Fleeger v. Wyeth (A08-2124), the federal district court in Little Rock, Arkansas presiding over the hormone therapy MDL proceedings certified a question to the Minnesota Supreme Court as to whether Minnesota’s statutes of limitations would govern the claims of out-of-state plaintiffs who sued out-of-state defendants for claims that accrued elsewhere. More »
Wyeth Pharmaceuticals has agreed to settle the hormone replacement therapy lawsuits filed by two Las Vegas women against the company. Vesta Woodhouse and Annie Woods had alleged that using Wyeth’s HRT drugs Prempro and Premarin caused them to develop breast cancer.
A judge in Nevada has refused to overturn a $134 million verdict awarded in a hormone replacement therapy lawsuit filed against Wyeth Co. Judge Robert Perry also refused to grant the company a new trial because of certain jury instructions issued in the lawsuit filed by three women who developed breast cancer after using hormone replacement therapy drugs.
The Food and Drug Administration has warned companies that market bio-identical hormone replacement therapy over the Internet to stop selling them to consumers. A warning letter sent to the companies stated that they were violating federal law by making false and misleading claims about the effectiveness of bio-identical hormone replacement therapy drugs.
A new study in the Journal of the National Cancer Institute has found that a drop in the number of new breast cancer cases in recent years was caused by a decline in the number of women undergoing hormone replacement therapy. The study, conducted by doctors at Portland, Oregon’s Kaiser Permanente Northwest Hospital, refuted speculation that the drop may have been caused by lower numbers of women receiving mammograms.
A new study suggests that older women who are long past menopause should not use hormone replacement therapy to prevent heart disease. An article published in the British Medical Journal says that older women face a much higher risk of hormone replacement therapy side effects from cardiovascular problems such as heart attacks and stroke.